Senior Director, Global Oncology Health Economics Outcomes Research & Real-World Evidence
Company: Daiichi Sankyo, Inc.
Location: Basking Ridge
Posted on: March 20, 2023
|
|
Job Description:
Join a Legacy of Innovation 110 Years and Counting!Daiichi
Sankyo Group is dedicated to the creation and supply of innovative
pharmaceutical therapies to improve standards of care and address
diversified, unmet medical needs of people globally by leveraging
our world-class science and technology. With more than 100 years of
scientific expertise and a presence in more than 20 countries,
Daiichi Sankyo and its 15,000 employees around the world draw upon
a rich legacy of innovation and a robust pipeline of promising new
medicines to help people. Under the Group's 2025 Vision to become a
"Global Pharma Innovator with Competitive Advantage in Oncology,"
Daiichi Sankyo is primarily focused on providing novel therapies in
oncology, as well as other research areas centered around rare
diseases and immune disorders.
Summary
The purpose of this role is to develop and drive the Global HEOR
and RWE strategies for the assigned oncology franchise products, in
alignment with key global and regional functions. The Global Sr
Director of HEOR & RWE Oncology will lead the HEOR and RWE asset
team in the execution of the market access strategy and evidence
generation activities across Daiichi-Sankyo. He/She will build and
drive the asset specific HEOR strategy and coordinate all
corresponding HEOR and RWE activities under the Global Oncology
Value Access & Pricing department for the Oncology Business Unit,
in collaboration with cross-functional teams. The role will be
responsible for the HEOR and RWE strategy and tactical plans,
including decision making and people management in the conduct of
global health economic models, global value dossiers, RWE studies,
PRO analysis, and will develop plans for innovative tools, methods,
and strategies to ensure successful market access and support the
company's vision of being a leader in oncology and deliver the
innovative Daiichi Sankyo's treatments to patient. The Sr Director
will direct and supervise evidence generation strategies and
tactics, both through cross-functional teams and management of
subordinates. Reports directly to the Vice President and Global
Head of Oncology HEOR and RWE and has the responsibility to build a
robust global HEOR/RWE strategy and manage team members and
resources in order to execute on the strategy. The position will be
a key and visible expert leader, he/she will engage the clinical,
Medical Affairs and commercial organization and drive the product
evidence strategies to ensure an effective use of HEOR and RWE
methods. The Sr Director will provide HEOR and RWE strategic
direction to Global Project Teams (GPTs) and Global Brand Teams
(GBTs) and provide recommendations on such aspects as appropriate
comparators, target patient populations, clinical and economic
endpoints and patient-reported outcomes (PROs), ensuring the payer
perspective is incorporated in the assigned clinical development
programs and the evidence needed to support optimal market access
is addressed. The Sr Director will help set up new strategies for
the company and the HEOR team that will ensure a successful launch
our oncology products. Lead the team through direct line management
and arrange cross-functional working teams to drive process
improvements and efficiencies. Furthermore, the role will develop
HEOR sections in target product profiles (TPPs), product
development plans, clinical development plans, and
commercialization plans and other critical
documents.Responsibilities- Direct the team to ensure
cross-functional collaboration between Global Value Access and
Pricing and other internal stakeholders such as Medical Affairs,
Clinical Development, Marketing, Biostats, etc.- Supervise the
conduct of HEOR and RWE projects such as early economic models,
burden of illness studies, external control arms to support single
arm trials, and drive the development, analysis, and validation of
patient-reported outcome (PRO) instruments in clinical trials-
Propose and drive the implementation of analysis of clinical trial
data for cost effectiveness models and market specific ad-hoc
requests for reimbursement submissions- Assess RWE data gaps and
building cross-functional evidence generation strategy for payers
and reimbursement submissions- Lead the team in the preparation of
global value dossiers which present the product value propositions
and the supporting evidence, aligned with the product development
strategies and agreed/endorsed by the GPTs, GBTs, Regional HEOR and
market access, to realize an optimal value demonstration of the
products- Oversee the implementation of literature reviews to build
payer evidence, economic models, and Global Value Dossiers- Direct
and oversee the implementation of global cost effectiveness and
budget impact models for HTA submissions to support reimbursement
of indications for Daiichi Sankyo's oncology products- Decide on
HEOR and RWE communications (e.g. manuscripts, scientific forum
presentations, slide decks, symposia), in collaboration with
multi-functional teams, to build the peer reviewed published
evidence supporting the value propositions for assigned products-
Effectively manage external consultancies and contractors, ensuring
delivery according to key milestones, budget and to agreed and
expected quality- Maintain and continue to enhance knowledge about
HEOR methods and the evolving public health policy and
reimbursement environment in major (USA, Europe and Japan) and
other pertinent markets
Qualifications: Successful candidates will be able to meet the
qualifications below with or without a reasonable
accommodation.
Education Qualifications (from an accredited college or
university)- Bachelor's Degree required- Master's Degree In a
relevant discipline (e.g., health economics, medicine, pharmacy,
public health, epidemiology) required or- PhD In a relevant
discipline (e.g., health economics, medicine, pharmacy, public
health, epidemiology) required
Experience Qualifications- 10 or More Years In the healthcare or
pharmaceutical industry, 8 of which must be working in the HEOR
field required- Hands on experience with HEOR methodologies across
all phases of the product life cycle preferred- Track record of
successful application of HEOR & RWE with key external stakeholders
in major international markets preferred- Knowledge and experience
of Oncology therapy areas preferred
TravelAbility to travel up to 30%
Daiichi Sankyo, Inc. is an equal opportunity/affirmative action
employer. Qualified applicants will receive consideration for
employment without regard to sex, gender identity, sexual
orientation, race, color, religion, national origin, disability,
protected veteran status, age, or any other characteristic
protected by law.
Keywords: Daiichi Sankyo, Inc., Newark , Senior Director, Global Oncology Health Economics Outcomes Research & Real-World Evidence, Healthcare , Basking Ridge, New Jersey
Click
here to apply!
|